help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopes, E. S.
Right arrow Articles by Cunha, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopes, E. S.
Right arrow Articles by Cunha, G. R.

Endocrinology, Vol 137, 4225-4234, Copyright © 1996 by Endocrine Society


ARTICLES

Initiation of secretory activity of rat prostatic epithelium in organ culture

ES Lopes, BA Foster, AA Donjacour and GR Cunha
Anatomy Department, University of California, San Francisco 94143-0452, USA.

Functional differentiation of prostatic epithelium is manifested by the production of tissue specific secretory proteins. In vivo production of these proteins is dependent on the presence of serum androgens. A serum- free organ culture system was used to examine the initiation of prostatic epithelial cytodifferentiation in vitro using two rat prostate specific secretory proteins (DP-1 and probasin) as markers of epithelial cytodifferentiation. The dorsal-lateral and anterior prostatic (AP) lobes from 12-day-old rats were cultured for 6 days in serum-free medium in the presence or absence of androgens. At the start of culture, secretory proteins DP-1 and probasin were undetectable using Western blot analysis. DP-1 and probasin were produced by explants cultured in the presence of androgens but were not detected in the absence of androgens. Dose-response studies were carried out for testosterone (T), 5 alpha-dihydrotestosterone (DHT), 5 alpha-Androstan- 3 alpha, 17 beta-diol (3 alpha-Adiol), and two synthetic androgens: 17 alpha-methyl-19-nortestosterone (MENT) and methyltrienolone (R1881). All androgens used were capable of inducing expression of DP-1 and probasin in vitro. T, R1881, and Ment were effective at doses of 10(-7) M to 10(-9) M, whereas both DHT and 3 alpha-Adiol were able to induce DP-1 and probasin at concentrations as low as 10(-10) M. Estrogen (17 beta-Estradiol), hydrocortisone (11 beta, 17 alpha, 21-trihydroxypregn- 4-ene-3, 20-dione), and progesterone (4-pregnen-3, 20-Dione) were ineffective in inducing prostatic secretory activity. Hydroxyflutamide (alpha-alpha-alpha-trifluro-2-methyl-4'-nitro-m-lactoluidide ) blocked the induction of secretory activity elicited by T. From histological sections, it was observed that explants cultured with T exhibited tall columnar epithelial morphology with organized stromal components. Tissue sections of explants cultured without T exhibited a cuboidal to low columnar morphology with less organized stromal components when compared with glands cultured with T. A DNA synthetic index was established to measure proliferation in the explants at the end of the culture period. Explants cultured in the presence of T exhibited greater DNA synthetic activity than explants cultured in the absence of T (P < 0.05). Using this serum-free model, we can explore the mechanism for the initiation of secretory cytodifferentiation.


This article has been cited by other articles:


Home page
J ANIM SCIHome page
J. L. Vallet and B. A. Freking
Differences in placental structure during gestation associated with large and small pig fetuses
J Anim Sci, December 1, 2007; 85(12): 3267 - 3275.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Song, S. C. Cornelius, and D. Danielpour
Development and Characterization of DP-153, a Nontumorigenic Prostatic Cell Line That Undergoes Malignant Transformation by Expression of Dominant-negative Transforming Growth Factor {beta} Receptor Type II
Cancer Res., August 1, 2003; 63(15): 4358 - 4367.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society